The Novavax vaccine candidate is currently in late-stage clinical studies
- The company aims to deliver initial doses to Australia by mid-2021
- Australia will have the option to purchase up to an additional 10 million doses.
Australia to buy 51 million doses of Novavax's COVID-19 vaccine
Best in 2026
Sponsored
investingLive is a market news and analysis platform that lists and reviews forex brokers for informational use only. We do not provide investment advice or brokerage services. CFDs are complex, high-risk products and may not be suitable for all investors. investingLive is not responsible for any trading losses or decisions made based on content found on our site.
